Last €36.42 EUR
Change Today +0.157 / 0.43%
Volume 736.0
BRM On Other Exchanges
Symbol
Exchange
New York
Mexico
Sao Paulo
Frankfurt
As of 8:46 AM 07/22/14 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Beatrice Cazala

Former Executive Vice President, Bristol-Myers Squibb Company
AgeTotal Calculated CompensationThis person is connected to 0 board members in 0 different organizations across 1 different industries.

58$5,478,198
As of Fiscal Year 2013

Background*

Ms. Beatrice Cazala served as an Executive Vice President of Bristol-Myers Squibb Company from February 14, 2014 to June 9, 2014. Ms. Cazala served as an Executive Vice President of Commercial Operations at Bristol-Myers Squibb Company since October 2011. Ms. Cazala served as Senior Vice President of Commercial Operations & President of Europe and Emerging Markets at Bristol-Myers Squibb Company since from 2010 to 2011, and served as its President of Global Commercialization ...

Read Full Background

Corporate Headquarters*

345 Park Avenue
New York, New York 10154

United States

Phone: 212-546-4000
Fax: 212-546-4020

Board Members Memberships*

There is no Board Members Memberships data available.

Education*

There is no Education data available.

Other Affiliations*

There is no Company Affiliations data available.

Annual Compensation*

Salary$894,694
Total Annual Compensation$894,694

Stock Options*

Restricted Stock Awards$3,611,980
All Other Compensation$75,609
Exercised Options216,412
Exercised Options Value$3,974,876
Exercisable Options169,893
Exercisable Options Value$5,912,276
Total Value of Options$9,887,152
Total Number of Options386,305

Total Compensation*

Total Annual Cash Compensation$1,866,218
Total Short Term Compensation$894,694
Other Long Term Compensation$3,687,589
Total Calculated Compensation$5,478,198
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
BRM:GR €36.42 EUR +0.157

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Robert A. Bradway Chairman, Chief Executive Officer, President, Chairman of Executive Committee and Member of Equity Award Committee
Amgen Inc.
$1.5M
Miles D. White Chairman, Chief Executive Officer and Chairman of Executive Committee
Abbott Laboratories
$1.9M
John C. Lechleiter Ph.D.Chairman, Chief Executive Officer and President
Eli Lilly and Company
$1.5M
Lars Rebien Sørensen Chief Executive Officer
Novo Nordisk A/S
kr15.2M
Richard A. Gonzalez Chairman, Chief Executive Officer and Chairman of Executive Committee
AbbVie Inc.
$1.5M
Compensation as of Fiscal Year 2013.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact BRISTOL-MYERS SQUIBB CO, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.